REQUEST A DEMO
Total
USD $0.00
Search more companies

Zaklady Farmaceutyczne "Polpharma" S.A. (Poland)

Main Activities: Pharmaceutical and Medicine Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Zaklady Farmaceutyczne "Polpharma" S.A. Profile Updated: March 02, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English & Polish Download a sample report

Polpharma is among the 20 largest generics companies in the world, with a turnover of approx. 1 billion dollars a year. It employs more than 7,500 people in Poland and in some foreign markets. The company has 7 production plants in Poland, Russia and Kazakhstan, and 7 centers of research and development. Polpharma Group's portfolio includes about 600 products, and another 200 are under development. Polpharma SA specializes in cardiology, gastroenterology and neurology. A significant part of the product portfolio are the medications available over the counter (OTC). The company offer also includes dietary supplements, medical devices, cosmetics and herbal medicines.

Headquarters
Ul. Pelplinska 19
Starogard Gdanski; Pomorskie; Postal Code: 83-200

Contact Details: Purchase the Zaklady Farmaceutyczne "Polpharma" S.A. report to view the information.

Website: http://www.polpharma.pl

Basic Information
Total Employees:
Purchase the Zaklady Farmaceutyczne "Polpharma" S.A. report to view the information.
Outstanding Shares:
Purchase the Zaklady Farmaceutyczne "Polpharma" S.A. report to view the information.
Registered Capital:
Purchase the Zaklady Farmaceutyczne "Polpharma" S.A. report to view the information.
Financial Auditors:
Purchase the Zaklady Farmaceutyczne "Polpharma" S.A. report to view the information.
Incorporation Date:
August 22, 2002
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
"Biologiczne Technologie Farmaceutyczne" Sp. z o.o.
100%
Centrum Innowacji Farmaceutycznych Sp. z o.o.
100%
Centrum Syntezy Molekul Sp. z o.o.
100%
Company Performance
Financial values in the chart are available after Zaklady Farmaceutyczne "Polpharma" S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
12.22%
Total operating revenue
12.23%
Operating profit (EBIT)
32.83%
EBITDA
33.15%
Net Profit (Loss) for the Period
64.05%
Total assets
16.91%
Total equity
35.25%
Operating Profit Margin (ROS)
3.21%
Net Profit Margin
5.45%
Return on Equity (ROE)
4.52%
Debt to Equity Ratio
-10.83%
Quick Ratio
0.38%
Cash Ratio
0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?